NDC 69097-361 – Grisofulvin

Griseofulvin 125 mg/5mL · Suspension · Oral

Human Prescription Drug

Product NDC69097-361

Product details

Brand name
Grisofulvin
Generic name
Grisofulvin
Labeler
Cipla USA Inc.
Dosage form
Suspension
Route
Oral
Marketing category
ANDA · ANDA065354
Marketed since
March 6, 2017
Listing expires
December 31, 2026
Pharmacologic class
Tubulin Inhibiting Agent

Active ingredients

Uses, dosage, side effects and warnings for Grisofulvin →

Package NDC codes (1)

Package NDCDescriptionSince
69097-361-08120 mL in 1 BOTTLE (69097-361-08)Mar 6, 2017